Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

ALNYLAM PHARMACEUTICALS, INC.

Pharmaceutical Preparations | SIC: 2834
Phone: (617) 551-8200

CIK: 0001178670
EIN: 770602661
State Location: MA

Nasdaq:ALNY

Form: SCHEDULE 13G/A

Filing Date: 14 May 2026
Report Date:
Accepted: 14 May 2026 11:55 a.m.
Accession Number: 0001422849-26-000061

Act: 34
File Number: 005-79884
Film Number: 26977678

Documents

Primary Document

Accepted: 14 May 2026 11:55 a.m.

0001422849-26-000061-index-headers.html

Last Modified: 14 May 2026 11:55 a.m.

0001422849-26-000061-index.html

Last Modified: 14 May 2026 11:55 a.m.

0001422849-26-000061.txt

Last Modified: 14 May 2026 11:55 a.m.

primary_doc.xml

Last Modified: 14 May 2026 11:55 a.m.